Related Experiment Video
Updated: Jan 9, 2026

12:28
Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics
Published on: January 11, 2019
7.7K
Cdc20 turnover rate: a key determinant in cancer patient response to anti-mitotic therapies?
1Department of Biochemistry, University of Leicester, Leicester, UK. amf5@le.ac.uk
Abstract
No abstract available in PubMed .

